Spiramycin Tablets bulk supplier for pharma manufacturers

Spiramycin Tablets 3 MIU, 1.5MIU Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 3 MIU, 1.5MIU

Reference Brands: Rovamycine (EU/UK)

Spiramycin is used to treat many kinds of infections. It is often used to treat toxoplasmosis in pregnant women since this medicine decreases the chance that the unborn baby will get the infection.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Spiramycin Tablets? List it or send an offer →

Product Description:

Spiramycin is a macrolide antibiotic. Like others in its class it binds the 50S ribosomal subunit and blocks bacterial protein synthesis, but it has a property the others lack and which defines its use: it concentrates heavily in the placenta, reaching levels several times those in maternal blood, while crossing into the fetal circulation only poorly.

That distribution makes it the standard treatment for toxoplasmosis acquired during pregnancy. Given to the mother, it reduces the risk of the parasite being transmitted across the placenta to the fetus — roughly by half — while exposing the fetus itself to very little drug. It does not treat established fetal infection, for which pyrimethamine and sulfadiazine are used instead once the second trimester is reached. It is also used for susceptible respiratory and oral infections. Gastrointestinal upset is the usual adverse effect; QT prolongation is a class caution.

Sourcing notes. Off patent, but registered in a limited set of countries — widely available in France and much of Europe, and not approved in the United States except through a named-patient route. Confirm registration per destination. Demand is driven by antenatal toxoplasmosis screening programmes, which exist in some countries and not others. Strengths are expressed in million international units.

Spiramycin Tablets — third party manufacturing & bulk supply

Spiramycin Tablets 3 MIU, 1.5MIU is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Spiramycin Tablets is supplied as Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Spiramycin Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Spiramycin Tablets →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Spiramycin is used to treat various bacterial infections, particularly those caused by susceptible organisms, including respiratory tract infections, skin infections, and oral infections. It is also used in specific cases such as toxoplasmosis during pregnancy to help reduce fetal transmission.

Spiramycin is a macrolide antibiotic produced by the bacterium Streptomyces ambofaciens. It is composed of large lactone rings with attached sugar molecules, giving it typical macrolide antibacterial activity.

Spiramycin is marketed under several trade names worldwide, including Rovamycine. Brand names may vary by region, but Rovamycine is the most widely recognized.

Rovamycine, one of the main brand names of Spiramycin, is manufactured by Sanofi. Other manufacturers may exist depending on the country and regulatory approvals.

The generic name of the product is spiramycin.

Common brand names include Rovamycine, with additional regional brands available depending on the market.

Spiramycin is manufactured in multiple countries, depending on the pharmaceutical company’s production facilities. Sanofi manufactures Rovamycine in its approved global manufacturing sites, and other generic manufacturers produce Spiramycin in various regions according to local regulatory guidelines.